SCHEMBL3793

SCHEMBL3793

CNCO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methyl Alcohol SCHEMBL11662814 0.95
Bromide SCHEMBL3798899 0.95
Hydrochloric Acid SCHEMBL909133 0.95 KDM4E (0.33)
Water SCHEMBL5185846 0.95
Hydrochloric Acid SCHEMBL243977 0.95
Methyl Alcohol SCHEMBL11583267 0.91
Methyl Alcohol SCHEMBL11568348 0.91
SCHEMBL28613907 0.91
SCHEMBL9366540 0.87 ALDH1A1 (0.33)
Acetic Acid SCHEMBL3431821 0.80 FFAR3 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 5385 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4687851-A1 SOLID ORAL DOSAGE FORM COMPRISING ANTIBODIES FOR SUSTAINED RELEASE IN THE LOWER GASTROINTESTINAL TRACT TILLOTTS PHARMA AG (CH) 2026-02-11 EP claimed
US-20250361266-A1 USE OF RAMAN SPECTROSCOPY IN DOWNSTREAM PURIFICATION REGENERON PHARMA (US) 2025-11-27 US claimed
US-20250312297-A1 REDUCTION OF HEALTHCARE RESOURCE UTILIZATION BY PATIENTS TREATED WITH INTRANASALLY-ADMINISTERED METOCLOPRAMIDE EVOKE PHARMA, INC. 2025-10-09 US claimed
US-20250302777-A1 METHODS FOR TREATING GASTROPARESIS EVOKE PHARMA, INC. 2025-10-02 US claimed
US-20250228803-A1 NASAL FORMULATIONS OF METOCLOPRAMIDE EVOKE PHARMA, INC. 2025-07-17 US claimed
CN-116103837-B High-temperature-resistant polyimide composite diaphragm and preparation method thereof 湖州南木纳米科技有限公司 2025-06-10 CN claimed
CN-119978177-A Raw material composition of solid titanium catalyst component, catalyst, preparation method and application thereof 中国石油化工股份有限公司 2025-05-13 CN claimed
US-20250127722-A1 SOLID ORAL DOSAGE FORM COMPRISING ANTIBODIES FOR SUSTAINED RELEASE IN THE LOWER GASTROINTESTINAL TRACT TILLOTTS PHARMA AG (CH) 2025-04-24 US claimed
EP-4539934-A1 TREATMENT FOR GLOMERULAR DISEASES Zydus Lifesciences Limited (IN) 2025-04-23 EP claimed
WO-2025056716-A1 KITS AND METHODS FOR PRESERVATION OF BIOLOGICAL SAMPLES Technische Universität München, in Vertretung des Freistaates Bayern (DE) 2025-03-20 WO claimed
WO-1993017676-A1 ANTIFUNGAL AGENTS JEMLAN, INC. (US) 1993-09-16 WO claimed
EP-0180812-B1 3,6 BIS(SUBSTITUTED) ACRIDINE DERIVATIVES AMERICAN CYANAMID COMPANY (US) 1991-05-15 EP claimed
EP-0375225-A2 Palladium alloy plating process AT&T Corp. (US) 1990-06-27 EP claimed
US-4759861-A Consists of an aliphatic mono- or di-carboxylic acid, a dimer or trimer of said dicarboxylic acid, petroleum sulfonic acid and naphthenic acid or salt NIPPON OIL CO., LTD. (JP) 1988-07-26 US claimed
EP-0196743-A2 Stable chemical compositions containing chromogenic materials and peroxides, and method for obtaining them SAVYON DIAGNOSTICS LTD. (IL) 1986-10-08 EP claimed
US-4495077-A REACTING ETHANOLAMINE WITH KETO ACIDS DERIVED FROM ALKENYL SUCCININIC ACID ANHYDRIDES TEXACO INC. (US) 1985-01-22 US claimed
EP-0049975-B1 OIL-SOLUBLE NITROGEN CONTAINING SULFONATED POLYMERS USEFUL AS OIL ADDITIVES EXXON RESEARCH AND ENGINEERING COMPANY (US) 1984-07-11 EP claimed
EP-0047300-A1 METHOD FOR TREATING COAL TO OBTAIN A REFINED CARBONACEOUS MATERIAL JENKINS, Rodman (US) 1982-03-17 EP claimed
US-4319980-A Method for treating coal to obtain a refined carbonaceous material JENKINS RODMAN 1982-03-16 US claimed
WO-1981002580-A1 METHOD FOR TREATING COAL TO OBTAIN A REFINED CARBONACEOUS MATERIAL JENKINS R 1981-09-17 WO claimed